HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helmi Mardassi Selected Research

GTYRAC-specific type II deoxyribonucleases

12/2014IS6110-5'3'FP: an automated typing approach for Mycobacterium tuberculosis complex strains simultaneously targeting and resolving IS6110 5' and 3' polymorphisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helmi Mardassi Research Topics

Disease

4Tuberculosis (Tuberculoses)
12/2014 - 11/2006
1Diarrhea
02/2021
1Lymphadenitis (Adenitis)
12/2020
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
02/2016

Drug/Important Bio-Agent (IBA)

2lipoarabinomannan (LAM)IBA
07/2008 - 04/2008
1ParaffinIBA
12/2020
1Formaldehyde (Formol)FDA Link
12/2020
1Rifampin (Rifampicin)FDA LinkGeneric
02/2016
1GTYRAC-specific type II deoxyribonucleasesIBA
12/2014
1DNA (Deoxyribonucleic Acid)IBA
11/2006

Therapy/Procedure

1Length of Stay
02/2021